Growth Metrics

Plus Therapeutics (PSTV) Asset Utilization Ratio (2016 - 2025)

Plus Therapeutics (PSTV) has disclosed Asset Utilization Ratio for 15 consecutive years, with 0.3 as the latest value for Q4 2025.

  • Quarterly Asset Utilization Ratio fell 65.19% to 0.3 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.3 through Dec 2025, down 65.19% year-over-year, with the annual reading at 0.45 for FY2025, 29.74% down from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.3 at Plus Therapeutics, down from 0.36 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 1.09 in Q1 2024, with the low at 0.07 in Q1 2021.
  • Average Asset Utilization Ratio over 5 years is 0.34, with a median of 0.3 recorded in 2025.
  • The sharpest move saw Asset Utilization Ratio surged 7630.43% in 2023, then tumbled 65.19% in 2025.
  • Over 5 years, Asset Utilization Ratio stood at 0.04 in 2021, then soared by 121.38% to 0.01 in 2022, then soared by 7630.43% to 0.66 in 2023, then rose by 30.0% to 0.86 in 2024, then crashed by 65.19% to 0.3 in 2025.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods came in at 0.3, 0.36, and 0.47 for Q4 2025, Q3 2025, and Q2 2025 respectively.